Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma : clinical and biomarker analysis

• JONASCH E

収録刊行物

• Cancer

  Cancer 116 57-65, 2010

詳細情報

• CRID: 1572543025681861248
• NII論文ID: 10030720405
• データソース種別:
  • CiNii Articles